• LAST PRICE
    1.0500
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (0.9615%)
  • Bid / Lots
    0.9800/ 1
  • Ask / Lots
    1.1000/ 10
  • Open / Previous Close
    1.0200 / 1.0400
  • Day Range
    Low 0.9901
    High 1.0700
  • 52 Week Range
    Low 0.7000
    High 3.8800
  • Volume
    42,365
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.04
TimeVolumeCTSO
02:38 ET65031.02
02:56 ET78581.03
03:23 ET1001.05
03:34 ET1751.06
03:38 ET2251.06
03:41 ET3001.07
03:48 ET3651.07
03:52 ET4741.07
03:54 ET47471.0699
03:56 ET1031.07
03:57 ET4741.05
03:59 ET6001.05
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCTSO
Cytosorbents Corp
59.7M
-1.8x
---
United StatesBNGO
Bionano Genomics Inc
46.0M
-0.1x
---
United StatesLNSR
LENSAR Inc
60.5M
-4.3x
---
United StatesSSKN
STRATA Skin Sciences Inc
10.9M
-1.1x
---
United StatesAAXT
Aamaxan Transport Group Inc
1.6K
0.0x
---
United StatesOLYMY
Olympus Corp
20.0B
116.6x
---
As of 2024-07-19

Company Information

CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in intensive care (ICU) and cardiac surgery using blood purification via its proprietary polymer adsorption technology. The Company’s flagship product, CytoSorb, is an extracorporeal cytokine absorber, designed to reduce the cytokine storm or cytokine release syndrome that could otherwise cause massive inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury, cytokine release syndrome due to cancer immunotherapy, and pancreatitis. Its other products include CytoSorb, animal-targeted VetResQ, DrugSorb-ATR and ECOS-300CY. Its other product candidates under development, including CytoSorb XL, BetaSorb, ContrastSorb, DrugSorb, HemoDefend-RBC, HemoDefend-BGA, K+ontrol, and others consist of a cartridge containing adsorbent, porous polymer beads, although the polymers used in these devices are physically different.

Contact Information

Headquarters
305 COLLEGE ROAD EASTPRINCETON, NJ, United States 08540
Phone
973-329-8885
Fax
---

Executives

Independent Non-Executive Chairman of the Board
Michael Bator
President, Chief Operating Officer
Vincent Capponi
Chief Executive Officer, Director
Phillip Chan
Interim Chief Financial Officer
Kathleen Bloch
Chief Medical Officer
Efthymios Deliargyris

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$59.7M
Revenue (TTM)
$36.7M
Shares Outstanding
54.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.62
EPS
$-0.59
Book Value
$0.43
P/E Ratio
-1.8x
Price/Sales (TTM)
1.6
Price/Cash Flow (TTM)
---
Operating Margin
-76.99%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.